Trial intelligence / Profile preview

Chloroquine in Pre-operative Breast Cancer (CUBiC)

NCT02333890Phase 2Unknown

Sponsor
Ottawa Hospital Research Institute
Start
Jul 2015
Primary completion
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of chloroquine in invasive breast cancer, sponsored by Ottawa Hospital Research Institute. Status: unknown.

02

Drugs

chloroquine
03

Conditions

invasive breast cancer

Beyond the preview

Go deeper on NCT02333890.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02333890.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call